Role of p53 and p21 polymorphisms in the risk of cervical cancer among Chinese women

被引:23
作者
Jiang, Pei [1 ,2 ]
Liu, Jianxin [1 ]
Li, Wen [1 ]
Zeng, Xiaoxi [2 ]
Tang, Jianxin [1 ,2 ]
机构
[1] Cent S Univ, Sch Infophys & Geomat Engn, Changsha 410083, Peoples R China
[2] Hunan Univ Technol, Key Lab Green Packaging & Applicat Biol Nanotechn, Zhuzhou 412007, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
p53; p21; genetic polymorphism; cervical cancer; DEPENDENT KINASE INHIBITOR; CODON; 72; POLYMORPHISM; TP53; CODON-72; ASSOCIATION; SUSCEPTIBILITY; GENE; HAPLOTYPE;
D O I
10.1093/abbs/gmq069
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The objective of this study was to identify whether polymorphic variants of p53 at codon 72 and p21 at codon 31 were associated with increased risk for cervical cancer, either independently or jointly, among Chinese women from southern Han. We genotyped p53 codon 72 and p21 codon 31 polymorphisms of peripheral blood DNA from 104 cervical cancer patients and 160 controls. Genotyping was confirmed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and direct DNA sequencing. We observed an increased risk of cervical cancer associated with the p53 Arg/Arg (OR, 2.25; 95% CI, 1.11-4.54) or p21 Ser/Ser (OR, 2.09; 95% CI, 1.04-4.19) genotype, compared with the p53 Pro/Pro or p21 Arg/Arg genotype, respectively. In additional, interaction between these p53 and p21 polymorphisms increased the risk of cervical cancer in a multiplicative manner, with the OR being 3.96 (95% CI, 1.51-10.41) for subjects carrying both p53 Arg/Arg and p21 Ser/Ser genotypes. These findings suggest that there is a significant association between the genetic polymorphism of p53, p21, and the risk of cervical cancer among Chinese southern women, and there is a possible gene-gene interaction in the incidence of cervical cancer.
引用
收藏
页码:671 / 676
页数:6
相关论文
共 37 条
[1]   The significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas [J].
Andersson, S ;
Rylander, E ;
Strand, A ;
Sällström, J ;
Wilander, E .
BRITISH JOURNAL OF CANCER, 2001, 85 (08) :1153-1156
[2]  
[Anonymous], 1994, GENES DEV
[3]   Codon 72 polymorphism of p53 in Israeli Jewish cervical cancer patients and healthy women [J].
Arbel-Alon, S ;
Menczer, J ;
Feldman, N ;
Glezerman, M ;
Yeremin, L ;
Friedman, E .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2002, 12 (06) :741-744
[4]   Novel polymorphism in p21waf1/cip1 cyclin dependent kinase inhibitor gene:: association with human esophageal cancer [J].
Bahl, R ;
Arora, S ;
Nath, N ;
Mathur, M ;
Shukla, NK ;
Ralhan, R .
ONCOGENE, 2000, 19 (03) :323-328
[5]   Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women [J].
Bhattacharya, P ;
Sengupta, S .
GYNECOLOGIC ONCOLOGY, 2005, 99 (01) :176-182
[6]   The codon 31 polymorphism of the p53-inducible gene p21 shows distinct differences between major ethnic groups [J].
Birgander, R ;
Sjalander, A ;
Saha, N ;
Spitsyn, V ;
Beckman, L ;
Beckman, G .
HUMAN HEREDITY, 1996, 46 (03) :148-154
[7]   Comprehensive assessment of P21 polymorphisms and lung cancer risk [J].
Choi, Yi Young ;
Kang, Hyo-Kyung ;
Choi, Jin Eun ;
Jang, Jin Sung ;
Kim, Eun Jin ;
Cha, Sung Ick ;
Lee, Won Kee ;
Kam, Sin ;
Kim, Chang Ho ;
Han, Sung Beom ;
Jung, Tae Hoon ;
Park, Jae Yong .
JOURNAL OF HUMAN GENETICS, 2008, 53 (01) :87-95
[8]  
Franco EL, 2001, CAN MED ASSOC J, V164, P1017
[9]  
Harima Y, 2001, INT J MOL MED, V7, P261
[10]  
HOU MM, 2006, INT J GYNECOL CANCER, V16, P2004